3. Simplified Illustration of EEG measurement while conducting eye tracking min scaled 1
Screenshot 2021 07 08 at 17.04.12 1 min
Screenshot 2021 07 08 at 17.04.12 1 min
20180912 AKJ8011 oc kopi scaled e1613640250688
IMG 68661 min scaled min 1 1
OUR RESEARCH

Digital Therapeutics Solutions

to neurological and psychiatric disorders
ANXIETY & DEPRESSION

Advancing New Technologies for

Brain Stimulation

OUR RESEARCH

Science & Research

Check out our publications and learn more about non-invasive brain stimulation
OUR RESEARCH

Get Involved with Our Research

previous arrow
next arrow
main pic homepage compressed min min scaled e1631690892143 min

Advancing Innovative Digital Therapeutics Solutions

At Optoceutics, we are committed to developing disease-modifying digital therapeutics (DTx) for neurodegenerative and psychological disorders such as Alzheimer’s, MCI, ADHD, and depression.

We work at the intersection of neuroscience, engineering and artificial intelligence to create preventive health solutions that are safe, non-invasive and drug-free.

A TOOL FOR BETTER STIMULATION

Our App Will Help You Track Your Progress [In Development]

Maximize your brain stimulation experience with OPTOINSIGHT ®

> Customize the brightness of the lamp

> Optimize the masked light according to your personal preferences

> Track your usage of the device

app gif eng 1

Investigating Gamma Brain Waves for Alzheimer’s Disease

Optoceutics is currently conducting a clinical study to investigate the potential effect of masked 40 Hz flickering light on Alzheimer’s disease patients.

DISCLAIMER: All devices used in trials are considerd investigational devices and limited to investigational use only.

homepage collage 1024x1024 1

Selected Partners

Latest News

Press & Mentions

Read more about the team behind the project.

Where to Find Us